Pancrelipase

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1880.0%

Death Rate

Active Ingredients

Pancrelipase

Administration Routes

OralUnknown

Species Affected

Dog 15

Human 1

Most Affected Breeds

Shepherd Dog - German 8

Corgi (unspecified) 2

Unknown 1

Retriever - Labrador 1

Pinscher - Miniature 1

Spaniel - King Charles 1

Pug 1

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Most Reported Reactions

Other abnormal test result NOS 4

Diarrhoea 4

Vomiting 4

Anaemia NOS 2

Leucocytosis NOS 2

Death by euthanasia 2

Hypoalbuminaemia 2

Elevated total bilirubin 2

Haemorrhage NOS 2

Splenomegaly 2

PR-LIVER, LESION(S) 2

Abnormal stool colouration 2

Outcome Breakdown

Recovered/Normal

5 (31.3%)

Outcome Unknown

5 (31.3%)

Euthanized

2 (12.5%)

Ongoing

2 (12.5%)

Died

1 (6.3%)

Recovered with Sequela

1 (6.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.